CalciMedica Inc. (CALC) vs CASI Pharmaceuticals Inc. (CASIF)

CalciMedica Inc. and CASI Pharmaceuticals Inc. are both Biotechnology companies. CalciMedica Inc. and CASI Pharmaceuticals Inc. are of similar size ($12.4M and $11.9M). CalciMedica Inc. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, CalciMedica Inc. leads on 6 and CASI Pharmaceuticals Inc. on 6.

Valuation

Metric CALC CASIF Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.12 11.47
P/B 1.09 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.05 n/m 0.74
EV/Sales n/m 1.81 10.73
Earnings yield (385.71%) (1,984.62%) (28.84%)
Free cash flow yield (318.85%) (3,717.40%) (23.03%)

Profitability

Metric CALC CASIF Biotechnology median
Gross margin 0.00% 48.65% 65.16%
Operating margin 0.00% (206.87%) 0.00%
Net margin 0.00% (232.03%) 0.00%
Free cash flow margin 0.00% (432.54%) 0.00%
Return on equity (365.70%) 0.00% (57.72%)
Return on assets (110.10%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CALC CASIF Biotechnology median
Revenue growth (TTM) — (27.42%) 5.64%
EPS growth (last fiscal year) (61.48%) (1.17%) —
Revenue growth, 5-year CAGR — 6.47% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CALC CASIF Biotechnology median
Debt to equity 1.67 (0.34) 0.00
Current ratio 5.58 0.15 4.73
Net debt to EBITDA 0.14 (0.43) 0.96

Dividend

Metric CALC CASIF Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CALC CASIF Biotechnology median
Market cap 11.88m 12.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack